Cabaletta Bio, Inc.

CABA

$3.45

-0.89%

2026-09-04 12:56:38 EDT-$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Loading executive datasets...

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Steven A. Nichtberger	Co-Founder, Chairman, Chief Executive Officer & President	USD 1,134,577	—	1961	Active
David J. Chang FACR	Chief Medical Officer	USD 807,135	—	1963	Active
Gwendolyn K. Binder	President of Science & Technology	USD 773,962	—	1975	Active
Anup Marda	Chief Financial Officer	USD 548,197		1978	Active
Michael Gerard	General Counsel & Secretary	—		1980	Active
Samik Basu	Chief Scientific Officer	—	—	—	Active
Aimee Payne	Co-Founder & Co-Chair of Scientific Advisory Board	—	—	—	Active
Michael C. Milone	Co-Founder & Co-Chair of Scientific Advisory Board	—	—	—	Active
Heather Harte-Hall	Chief Compliance Officer	—		—	Active
Qing Sarah Yuan	Chief Technology Officer	—	—	1971	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer